Paul Mampilly on the Greatest Medical Breakthrough

Mr. Paul Mampilly is a senior editor in several of America’s significant newsletters that are published by Banyan Hill Company. The specialty of Mr. Paul Mampilly is in the appropriate research and publishing of works, aimed at helping Main Street Americans acquire wealth through investments in selected market opportunities. In this endeavor, he uses his over twenty-five-year experience as a Wall Street insider, to pinpoint small companies with promising business models and products then shares it with thousands of interested investors. The MBA graduate of Fordham University has many achievements to his name including the winning of the Templeton Foundation Investment Competition in 2008 to 2009. Read more at PRNewswire about Paul Mampilly.

In a recent article by Stock Gumshoe, Travis Johnson reviews Mr. Paul Mampilly’s teaser pitch, for his Profits, Unlimited Newsletter titled the Greatest Medical Breakthrough in History. Mr. Paul Mampilly claimed that he had identified the leading company in precision medicine revolution. He wrote that this company from the mid-Western regions of America was on the verge of realizing the most significant medical breakthrough humanity has ever seen. The company that he is vouching for is said to be making substantial leaps towards attempts in identifying medicine and treatments that work best on the individual through the extensive study of their genetic make-up. The company is trying to find means of designing medicine fit for exact DNA configuration and alleviate the possibilities of certain kinds of diseases. Read more about Paul on

Lots of different companies fit the description provided by the renowned editor. Some are involved in the actual genetic testing or the building of equipment designed to carry out these tests while others are focused on the customization of the treatment. To shed more light on the specific company in question, he adds that it’s among the leading in the molecular diagnostics DNA sequencing industry. More specifically this company’s efforts are channeled towards establishing permanent solutions for various forms of cancer.

Stock Gumshoe deduces with certainty that the company in question is Myriad Genetics. Myriad Genetics is a personalized medicine and diagnostics company that make their fortune by processing and selling tests that identify specific cancers. They also specialize in the prediction of cancer progression and offer the most effective treatment plan. Just like Mr. Mampilly predicted, the company’s stock performed well. A series of profits has seen the company shares rise significantly. Myriad Genetics’ stock stood at $1.5 billion last summer and is currently at the $2.2 billion mark.


Bradesco Under The Management Of Luiz Carlos Trabuco

Luiz Carlos Trabuco is one of the most respected and known entrepreneur in South America. Having a good education, he has the skills and knowledge which has enabled him to invest broadly. He is an ambitious man whose dreams and visions made him start his career at a tender age. After working in several positions in Bradesco bank, he managed to make one of the biggest deals ever known which involved the purchase of another bank in Brazil. This occurred after his decade of working as the chairman of finance hence, he was experienced in the ways to use money to make more money.

It is after the closing of HSBC business deal that he got a promotion. Luiz Carlos Trabuco was elected as the entrepreneur of the year as he had improved Bunco Bradesco to greater heights. The deal was first approved by Brandao of which after the acquisition, the Bunco Bradesco became at par with the leading bank. The company was at par with the leading bank in Brazil as Luiz Carlos Trabuco ensured the account holders increased to almost the same number and the assets were almost of the same value.


In his tenure, he was able to double the standards of Bradesco, a pension operating bank, to the extent of being known in the whole country and be ranked one of the largest banks. He was later given the position of the Vice President of Bradesco where he used the position to enlarge the company even more. Luiz Carlos Trabuco was at some point give the position as the vice-chairman of Board of Directors where he expanded the company largely. One of the ways he grew the company is by actively participating in the signing of marketing action at Lagoa. He was also able to make the company the largest in Latin America.

With the growth of the company, the management sector had to be restructured for better results and outcome. Therefore, the Unibrad University was started to educate the employees in order to ensure their polish their working skills. This helped to gauge and re-elect different employees for different positions according to their skills and knowledge. Therefore, it is through the evaluation and training that Luiz Carlos announced and approved Octavio de Lazaro Junior as the executive chair of the bank. Octavio started from low positions as he started as a continuum in the company and through hard work and excellent work done, he ended up with the position. Currently, he is the president of financial institution and the head of Bradesco Seguros group at his mid-fifties. The approval of the position is due to his experience and knowledge he has. Over the years he has proved to be an efficient worker with an added value of his education as he holds an economic degree.

Luiz Carlos Trabuco is still the head of Board of Directors till the next general and annual meeting where the approval and appointments will take place. The restructuring is made to ensure the company maintains its status quoi and improves from national to international level. It also aims to give employees the correct ranks to enhance the customer service.